COVID-19 vaccine uptake and vaccine hesitancy in rheumatic disease patients receiving immunomodulatory therapies in community practice settings

Arthritis Rheumatol. 2022 Jun;74(6):1091-1092. doi: 10.1002/art.42067. Epub 2022 Apr 27.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Humans
  • Immunomodulation
  • Rheumatic Diseases* / drug therapy
  • Vaccination
  • Vaccination Hesitancy

Substances

  • COVID-19 Vaccines